Louisville Resident Dr. Bays Awarded the NLA’s 2015 President’s Service Award
Dr. Harold Bays is board certified in endocrinology and internal medicine, and has participated as an investigator for more than 400 Phase I-IV clinical trials regarding treatments for dyslipidemias, obesity, diabetes mellitus, hypertension and other metabolic and hormonal disorders. He is also a Diplomate of the American Board of Clinical Lipidology. As medical director and president of Louisville Metabolic and Atherosclerosis Research Center, Dr. Bays has written or served as a contributing author to approximately 200 published scientific manuscripts and book chapters, as well as over 100 scientific abstracts presented at major scientific meetings.
Dr. Bays is a fellow of the National Lipid Association (FNLA), fellow of the Obesity Society (FTOS) and fellow of the American Association of Clinical Endocrinologists (FACE). He has served as an adviser/consultant to numerous pharmaceutical companies with regard to drug development, protocol writing, statistical analyses, regulatory application, FDA Advisory panel presentations and patent assistance. Dr. Bays originated the term “adiposopathy” (“sick fat”), which defines how and when the pathologic consequences of adipose tissue accumulation promotes metabolic disease, including dyslipidemia, diabetes mellitus and hypertension.
Dr. Bays is a co-author of the NLA Annual Summary of Clinical Lipidology 2015, of the American Society of Bariatric Physician Obesity Algorithm, and was chairman of the National Lipid Association 2012 Adiposity and Dyslipidemia Consensus Conference and chairman of the 2010 American Association of Clinical Endocrinologist Adipose Tissue Pathophysiology State of the Science Conference.
About the National Lipid Association
The NLA is a multidisciplinary specialty society focused on prevention of cardiovascular disease and other lipid-related disorders. The NLA’s mission is to enhance the practice of lipid management in clinical medicine; one of its goals is to enhance efforts to reduce death and disability related to disorders of lipid metabolism in patients. Members include physicians (MDs and DOs), as well as allied health clinical team members, including PhD researchers, nurses, nurse practitioners, physician assistants, pharmacists, exercise physiologists and dietitians.
